60
1
11
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP2048L | α-helical CRF 9-41 acetate | α-helical CRF 9-41 acetate(90880-23-2 Free base) | CRFR |
α-helical CRF 9-41 acetate is a competitive antagonist of CRF2 (KB = 100 nM) and a partial agonist of CRF1 (EC50 = 140 nM). | |||
TP2047L | CRF (6-33) acetate(120066-38-8 free base) | CRFR | |
CRF (6-33) acetate is a corticotropin-releasing factor binding protein (CRFBP) inhibitor peptide; displaces CRF from CRFBP. Suppresses body weight gain and increases motor activity in obese rats in vivo. | |||
TP2047 | CRF(6-33)(human) | CRF (6-33) | |
CRF(6-33)(human) is a Corticotropin-releasing factor binding protein (CRFBP) inhibitor peptide; displaces CRF from CRFBP. Suppresses body weight gain and increases motor activity in obese rats in vivo. | |||
TP2048 | α-Helical CRF(9-41) | α-helical CRF 9-41 | |
Corticotropin-releasing factor receptor antagonist (Ki values are 17, 5 and 0.97 at human CRF1, rat CRF2α and mouse CRF2β receptors respectively). | |||
TP1191 | CRF, bovine | Corticotropin Releasing Factor bovine | |
CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM. | |||
TP1190 | CRF, bovine TFA (92307-52-3 free base) | CRF, bovine TFA,Corticotropin Releasing Factor bovine TFA | |
CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM.CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM[1]. CR... | |||
T75972 | CRF, bovine TFA | ||
CRF, bovine (TFA), acts as a potent agonist for the CRF receptor and effectively displaces [125I-Tyr]ovine CRF, demonstrating a K_i of 3.52 nM [1]. | |||
T83665 | α-Helical CRF (9-41) TFA | α-Helical Corticotropin-Releasing Factor (9-41) | |
α-Helical CRF (9-41) is a synthetic peptide antagonist that targets corticotropin-releasing factor (CRF), effectively inhibiting CRF-induced adrenocorticotropic hormone (ACTH) release both in vitro, with isolated rat ant... | |||
T75893 | CRF(6-33)(human) TFA | ||
CRF(6-33)(human) TFA acts as a competitive inhibitor of the Corticotropin-Releasing Factor Binding Protein (CRF-BP), selectively interacting with CRF-BP without affecting post-synaptic Corticotropin-Releasing Factor rece... | |||
T75891 | α-Helical CRF(9-41) TFA | ||
α-Helical CRF(9-41) TFA acts as a competitive antagonist for the CRF2 receptor, possessing a binding constant (K B) of approximately 100 nM. Additionally, it serves as a partial agonist for the CRF1 receptor, exhibiting ... | |||
TP1144 | Corticotropin-releasing factor (human) | Human corticotropin-releasing factor,Human CRF,Corticotropin-releasing factor human | |
Corticotropin-releasing factor human (Human CRF; Human corticotropin-releasing factor) is an immunomodulatory neuropeptide that acts to release ACTH from the anterior pituitary and stimulates the sympathetic nervous syst... | |||
T76602 | (D-Phe12,Nle21,38,α-Me-Leu37)-CRF (12-41) (human, rat) | ||
(D-Phe12,Nle21,38,α-Me-Leu37)-CRF (12-41) (human, rat) is a corticotropin-releasing factor (CRF) antagonist known to counteract the inhibitory effects of IL-1a on Luteinizing hormone (LH) production [1]. | |||
T12276 | NVS-CRF38 | Others | |
NVS-CRF38 is an antagonist of corticotropin-releasing factor receptor 1 (CRF1). | |||
T79793 | CRF1 receptor antagonist-1 | CFTR | |
CRF1 Receptor Antagonist-1 (Compound 2), a CRF1 receptor antagonist, is utilized in research pertaining to congenital adrenal hyperplasia (CAH) [1]. | |||
T69871 | ICRF-196 | ||
ICRF-196 is a Topoisomerase II Inhibitor and antineoplastic agent. | |||
T71177 | LCRF-0004 | ||
LCRF-0004 is a potent and selective RON receptor tyrosine kinase inhibitor. The RON receptor tyrosine kinase has been identified as an important mediator of KRAS oncogene addiction and is overexpressed in the majority o... | |||
T69870 | ICRF-193 | ||
ICRF-193 is a DNA topoisomerase II inhibitor. | |||
T25893 | NU/ICRF 500 | ||
NU/ICRF 500 is a novel anthracenyl-amino acid catalytic inhibitor of topoisomerase II. | |||
T60126 | 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1A)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(2-propyn-1-yl)-2-thiazolamine | Others , CRFR | |
4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1A)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(2-propyn-1-yl)-2-thiazolamine is an enantiomeric counterpart of SSR-125543. SSR-125543 is a potent CRF-R1 antagoni... | |||
TP1448L | Astressin acetate | Astressin acetate (170809-51-5 Free base) | CRFR |
Astressin acetate is an antagonist of corticotropin releasing factor (CRF) with low affinity for the CRF binding protein and high affinity for the cloned pituitary receptor(Ki = 2 nM). | |||
TP2221L | ANP (1-11), rat acetate | Atrial natriuretic factor (1-11) acetate,Atriopeptide (1-11) acetate | Others |
ANP (1-11), rat acetate (Atrial natriuretic factor (1-11) acetate) is one of the atrial natriuretic factors, inhibitors of CRF-stimulated ACTH secretion. | |||
TP1199L | Urotensin I acetate (83930-33-0 Free base) | CRFR | |
Urotensin I acetate, a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hC... | |||
T7361 | Verucerfont | NBI77860,GSK561679 | CRFR |
Verucerfont (NBI77860) is an antagonist of corticotropin-releasing factor receptor 1 (CRF1) . | |||
T16713 | R121919 | NBI30775 | Others |
R121919 (NBI30775) is a potent small molecule adrenocorticotropic hormone-releasing factor receptor 1 (CRF1) receptor antagonist with antidepressant and anxiolytic activity that inhibits the CRF1 receptor, the CRF2 recep... | |||
T12492 | Pivagabine | CXB-722 | GABA Receptor |
Pivagabine (CXB-722), a hydrophobic 4-aminobutyric acid derivative, exhibits neuromodulatory activity and successfully penetrates the blood-brain barrier in rats. It counteracts the impact of foot shock on GABAA receptor... | |||
TP1504 | Urocortin III, mouse TFA (357952-10-4 free base) | Urocortin III, mouse TFA | |
Urocortin III, mouse TFA is a corticotropin-releasing factor (CRF)-related peptide. Urocortin III preferentially binds and activates CRF-R2. Urocortin III (Ucn3) is a known component of the behavioral stress response sys... | |||
T76180 | Urocortin III (human) | ||
Urocortin III (human) is a corticotropin-releasing factor (CRF)-related peptide that primarily interacts with and activates the CRF receptor type 2 (CRF-R2), showing a specific distribution in the central nervous system ... | |||
T25864 | NGD9002 | NGD-9002,NGD 9002 | |
NGD9002 is a novel generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist agent. | |||
T76492 | (Tyr0)-Urocortin, rat | ||
(Tyr0)-Urocortin, rat, serves as a high-affinity agonist for both corticotropin-releasing factor receptor type 1 (CRF-R1) and type 2 (CRF-R2), demonstrating inhibitory binding constants (Ki) of 1-2 nM [1]. | |||
T31052 | CP-376395 HCl | CP-376395,UNII-5113G7FP34,CP376395 | |
CP 376395 hydrochloride is a potent and selective CRF-RI receptor antagonist. | |||
T33607 | NBI-34041 | NBI34041,SB 723620,SB-723620,SB723620 | |
NBI-34041 is an effective and high-affinity CRF1 receptor antagonist that effectively reduces endocrine responses to CRF(1) receptor-mediated pharmacological and behavioral challenges. | |||
T27057 | CP 154,526 | CP-154,526,CP154,526 | |
CP 154,526 is a selective CRF1 receptor antagonist (Ki = 2.7 nM). CP 154,526 blocks CRF-induced activation of adenylate cyclase and the HPA axis. | |||
T27666 | JNJ-19567470 | JNJ19567470 | |
JNJ-19567470 is a selective, non-peptide CRF receptor 1 antagonist. | |||
T76025 | Urocortin III, mouse TFA | ||
Urocortin III, mouse TFA, a corticotropin-releasing factor (CRF)-related peptide, preferentially activates CRF-R2 [1], demonstrating its significant role in the behavioral stress response system as a component of Urocort... | |||
T76204 | A-Helical Corticotropin Releasing Factor (9-41) | ||
α-Helical Corticotropin Releasing Factor (9-41) is a corticotropin releasing factor (CRF) antagonist that lowers plasma growth hormone (GH) levels in vivo [1] [2]. | |||
TP1020 | Urocortin, rat | Urocortin (Rattus norvegicus),Rat urocortin | |
Endogenous CRF agonist. Ki values are 13, 1.5 and 0.97 nM for hCRF1, rCRF2α and mCRF2β respectively. | |||
T70433 | Antalarmin | ||
Antalarmin is a CRF-1 antagonist. By blocking CRF-1 activity the release of ACTH is reduced, and chronic stress is decreased in response to chronic stress. Antalarmin could be useful in reducing the adverse health conseq... | |||
T37111 | Corticotropin-releasing factor (human) (acetate) | ||
Human CRF acetate is a chemical compound that effectively stimulates the synthesis and secretion of adrenocorticotropin in the anterior pituitary. | |||
T69374 | NGD 98-2 | ||
NGD 98-2 is a new generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist. | |||
T36373 | Urocortin II (mouse) (trifluoroacetate salt) | ||
Urocortin II is a neuropeptide hormone and member of the corticotropin-releasing factor (CRF) family which includes mammalian CRF , urocortin , urocortin III , frog sauvagine, and piscine urotensin I.1 Mouse urocortin II... | |||
TP1860 | Urocortin II, human | ||
Human urocortin (hUcn) II is a new member of the corticotropin-releasing-factor (CRF) family. It selectively binds to the CRF2 receptor. | |||
T35374L | (Ala13)-Apelin-13 acetate | Apelin receptor | |
(Ala13)-Apelin-13 acetate, an APJ antagonist, modulates CRF-induced enhanced colonic motility, visceral sensation, and gut barrier. | |||
T75976 | Urotensin I TFA | ||
Urotensin I (Catostomus urotensin I) TFA is a CRF-like neuropeptide that functions as an agonist for CRF receptors, demonstrating efficacy through pEC50 values of 11.46 for human CRF1, 9.36 for human CRF2, and 9.85 for r... | |||
T75804 | K41498 TFA | ||
K41498 TFA, an analog of antisauvagine-30 (aSvg-30), is a potent and highly selective antagonist of CRF2 receptors, exhibiting K i values of 0.66 nM, 0.62 nM, and 425 nM for human CRF 2α, CRF 2β, and CRF 1 receptors, res... | |||
T62444 | NBI-27914 | ||
NBI-27914 is a potent and selective CRFR1 antagonist. The CRF receptors CRFR1 and CRFR2 are members of the G protein-coupled receptor superfamily. | |||
T76510 | [Asu1,6-Arg8]Vasopressin | ||
[Asu1,6-Arg8]Vasopressin is a vasopressin agonist that enhances cyclic AMP accumulation and adrenocorticotropic hormone (ACTH) release triggered by corticotropin-releasing factor (CRF) in cultured rat anterior pituitary ... | |||
T35814 | Urocortin III (human) (trifluoroacetate salt) | ||
Urocortin III is a neuropeptide hormone and member of the corticotropin-releasing factor (CRF) family which includes mammalian CRF , urocortin , urocortin II , frog sauvagine, and piscine urotensin I.1 Human urocortin II... | |||
TP2121 | Sauvagine | ||
Corticotropin-releasing factor (CRF) receptor agonist. Ki values are 9.4, 9.9, and 3.8 nM for inhibition of 125I-[D-Tyr1]astressin binding to hCRF-R1, rCRF-R2a and mCRF-R2b respectively. | |||
TP1448 | Astressin | ||
Astressin is an amino-terminal truncated analog of CRF that retains high affinity binding to the extracellular domain of the receptor and is believed to act as a neutral competitive antagonist of receptor activation. | |||
T75894 | Sauvagine TFA | ||
Sauvagine TFA, a mammalian CRF agonist derived from a 40-amino-acid neuropeptide found in frog skin, effectively releases ACTH from rat pituitary cells. It exhibits pharmacological effects on diuresis, the cardiovascular... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T8150 | Nudifloramide | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide | PARP , Endogenous Metabolite |
Nudifloramide (1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide) is one of the end degradation products of nicotinamide-adenine dinucleotide (NAD). |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00906 | CRHBP Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Corticotropin-Releasing Factor-Binding Protein (CRHBP) is a 37 kDa secreted glycoprotein that binds both CRH and urocortin in a 42 kDa extracellular complex. The molecule is approximately 300 amino acids in length and de... | |||
TMPH-02608 | Corticoliberin Protein, Mouse, Recombinant (His & KSI) | Mouse | E. coli |
Hormone regulating the release of corticotropin from pituitary gland. Induces NLRP6 in intestinal epithelial cells, hence may influence gut microbiota profile. | |||
TMPY-03412 | GGCT Protein, Human, Recombinant (His) | Human | E. coli |
GGCT belongs to the gamma-glutamylcyclotransferase family. It catalyzes the formation of 5-oxoproline from gamma-glutamyl dipeptides, the penultimate step in glutathione catabolism. GGCT may play a significant role in ... | |||
TMPH-02555 | C1QL1 Protein, Mouse, Recombinant (His) | Mouse | P. pastoris (Yeast) |
May regulate the number of excitatory synapses that are formed on hippocampus neurons. Has no effect on inhibitory synapses. | |||
TMPY-02882 | HIV-1 (group M, subtype CRF07_BC) gp140 Protein (His) | HIV | HEK293 Cells |
HIV-1 (group M, subtype CRF07_BC) gp140 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 78.2 kDa. | |||
TMPY-01373 | HIV-1 (group M, subtype CRF07_BC) gp120 Protein (His) | HIV | HEK293 Cells |
HIV-1 (group M, subtype CRF07_BC) gp120 Protein (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 54.8 kDa and the accession number is I6TSC9. | |||
TMPH-00550 | Epstein-Barr virus (strain B95-8) BCRF1 Protein (His & Myc) | EBV | E. coli |
Plays a role in masking infected cells for immune recognition by cytotoxic T-lymphocytes. Down-regulates the expression of the host TAP1 gene (transporter associated with antigen processing), thereby affecting the transp... | |||
TMPY-04061 | HIV-2 (subtype CRF01_AB, strain 07JP_NMC716_clone_01) gp36 Protein (His & MBP) | HIV | E. coli |
HIV-2 (subtype CRF01_AB, strain 07JP_NMC716_clone_01) gp36 Protein (His & MBP) is expressed in E. coli expression system with His and MBP tag. The predicted molecular weight is 58.8 kDa and the accession number is L8B302... | |||
TMPY-01408 | HIV-1 (group M, subtype CRF07_BC) gp140 Protein (hFc) | HIV | HEK293 Cells |
HIV-1 (group M, subtype CRF07_BC) gp140 Protein (hFc) is expressed in HEK293 mammalian cells with Fc tag. The predicted molecular weight is 98 kDa. | |||
TMPY-06486 | HIV-1 (group M, subtype CRF07_BC) gp120 Protein (His), Biotinylated | HIV | HEK293 Cells |
HIV-1 (group M, subtype CRF07_BC) gp120 Protein (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 54.8 kDa and the accession number is AFM77980.1. | |||
TMPK-00474 | IL-22RA1 Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
IL-22 receptor, also known as IL-22 R alpha 1 and CRF2-9, is an approximately 65 kDa transmembrane glycoprotein in the type II cytokine receptor family (CRF).Component of the receptor for IL20, IL22 and IL24. Component o... |